Completed PHASE1 INTERVENTIONAL 1-arm NCT00588120

Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria

Investigations Into the Genotype and Phenotype of Unclassified Hyperoxaluria: Enteric Oxalate Absorption Study

Sponsor: Mayo Clinic

Conditions Enteric Hyperoxaluria Hyperoxaluria

Updated 8 times since 2017 Last updated: Feb 28, 2020 Started: Dec 31, 1998 Primary completion: Jan 31, 2020 Completion: Jan 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Enteric Hyperoxaluria and Hyperoxaluria and is currently completed. Mayo Clinic leads this study, which shows 8 recorded versions since 1998 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Apr 2020 — Jan 2021 [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed
Feb 2019 — Apr 2020 [monthly]

Active Not Recruiting PHASE1

▶ Show 3 earlier versions

Sep 2018 — Feb 2019 [monthly]

Active Not Recruiting PHASE1
Jun 2018 — Sep 2018 [monthly]

Active Not Recruiting PHASE1
Jan 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE1

First recorded

Dec 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institutes of Health (NIH)
Oxalosis and Hyperoxaluria Foundation (OHF)

Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rochester, United States